The Pathophysiological Role and Therapeutic Potential of C-Type Natriuretic Peptide in Pulmonary Hypertension
J Dignam - 2023 - qmro.qmul.ac.uk
Background: Pulmonary hypertension (PH) is a multi-faceted disease characterised by
vascular remodelling and elevated pressure in the pulmonary arteries. Whilst targeted …
vascular remodelling and elevated pressure in the pulmonary arteries. Whilst targeted …
Pathology of pulmonary vascular diseases
P Dorfmüller - Pulmonary circulation: diseases and their …, 2011 - books.google.com
Vascular lesions found in lungs of patients suffering from pulmonary hypertension are
classically being considered as responsible for the increase of pulmonary arterial pressures …
classically being considered as responsible for the increase of pulmonary arterial pressures …
先天性心脏病合并肺动脉高压患儿血清MMP-9, TIMP-1 与VEGF 的变化
曾红军， 于丽娟， 武艺飞， 庞玉生 - 广西医科大学学报, 2008 - cqvip.com
目的: 探讨先天性心脏病(以下简称先心病) 患儿血清中的基质金属蛋白酶-9 (MMP-9),
金属蛋白酶组织抑制物-1 (TIMP-1) 及血管内皮生长因子(VEGF) 表达水平及变化. 方法: 81 …
金属蛋白酶组织抑制物-1 (TIMP-1) 及血管内皮生长因子(VEGF) 表达水平及变化. 方法: 81 …
Neonates with congenital cardiac defects and pulmonary hypertension
AC Chang, D Macrae - Cardiology in the Young, 2009 - cambridge.org
PERSISTENT PULMONARY HYPERTENSION OF THE newborn can occur in association
with a number of conditions such as congenital diaphragmatic hernia, congenital capillary …
with a number of conditions such as congenital diaphragmatic hernia, congenital capillary …
Pathogenesis of pulmonary arterial hypertension
AW Trammell, AR Hemnes - Diagnosis and Management of Pulmonary …, 2015 - Springer
Pulmonary arterial hypertension (PAH) is a rare disease of the pulmonary vasculature
characterized by progressive vascular obliteration, right heart failure, and ultimately death …
characterized by progressive vascular obliteration, right heart failure, and ultimately death …
[PDF][PDF] 先天性心脏病相关性肺动脉高压肺组织芳香烃受体的表达及其与肺血管重构的相关性研究
罗鹏， 庞玲品， 吴源聪， 陈普文， 朱秀龙… - Chinese Circulation …, 2015 - chinacirculation.org
摘要目的: 了解先天性心脏病相关性肺动脉高压(CHD-PAH) 患者肺组织是否有芳香烃受体(AHR
) 表达, 同时探讨AHR 表达量与肺血管重构是否相关. 方法: 入选超声心动图和右心导管检查确诊 …
) 表达, 同时探讨AHR 表达量与肺血管重构是否相关. 方法: 入选超声心动图和右心导管检查确诊 …
[HTML][HTML] Pulmonary vascular changes in piglets with increased pulmonary blood flow and pressure
M Gorenflo, E Herpel, MV Ullmann, K Röhlig… - Virchows Archiv, 2007 - Springer
In this model of pulmonary vascular disease, high pulmonary blood flow was created by an
anastomosis between the left subclavian artery and the main pulmonary artery [Blalock …
anastomosis between the left subclavian artery and the main pulmonary artery [Blalock …
Serum and pulmonary vascular endothelial growth factor/receptors and haemodynamic measurements in cyanotic congenital heart disease with decreased …
I Tolunay, S Tunaoglu, N Akyürek, V Halid… - Cardiology in the …, 2011 - cambridge.org
Tetralogy of Fallot is the most common cyanotic congenital heart disease with decreased
pulmonary blood flow. Right-to-left shunt and infundibular pulmonary stenosis in this …
pulmonary blood flow. Right-to-left shunt and infundibular pulmonary stenosis in this …
[HTML][HTML] Plexogenic pulmonary hypertension associated with POEMS syndrome
T Czeczok, P Lin, E Yi - Respiratory medicine case reports, 2017 - Elsevier
Pulmonary hypertension is one of the well-known clinical manifestations of polyneuropathy,
organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) …
organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) …
Die Rolle von Axl und Gas6 bei der pulmonalen Hypertonie
N Kühn - 2021 - jlupub.ub.uni-giessen.de
Hintergrund und Zielsetzung: Die pulmonal arterielle Hypertonie (PAH) ist mit einer
erhöhten Proliferationsrate, Apoptoseresistenz, Angiogenese, der Fähigkeit zur Migration …
erhöhten Proliferationsrate, Apoptoseresistenz, Angiogenese, der Fähigkeit zur Migration …